Video

Adaptive cataract surgery system streamlines procedure

Author(s):

Harvey Uy, MD, has been using the Ally adaptive cataract treatment system at his clinic in the Philippines, and it is allowing him to be more efficient.

Video transcript

Note: This transcript has been lightly edited for clarity.

Harvey Uy, MD, Peregrine Eye and Laser Institute: I'm Dr. Harvey Uy, from the Peregrine Eye and Laser Institute in the Philippines. I have been doing a femtosecond laser-assisted cataract surgery for a decade now. And it is wonderful technology, but it had some limitations. First of all, in my population of Asian eyes, sometimes it's very hard to put the PID on the eye. Secondly, it does take some time to transfer the patient from the laser area to the cap track area. So that's inefficient. And thirdly, we have to have defined space to have two machines in the operating theatre.

A new integrated femto laser and phaco machine, called the Ally system from Lensar, has come into the market, and it addresses many of our concerns. With this single system, we're able to bring the patient under one machine and perform the entire surgery in a single sterile environment.

The suction of this new machine is very good. So we're able to do the surgery even in small eyes, deep set eyes. We are able to complete the whole procedure faster, because we are able to scan the eye in just one go. The laser is two to four times faster than with the previous models.

And the most wonderful thing is after I do the laser part, I don't have to get up, the patient doesn't have to move. We can immediately proceed with the phacoemulsification. So this overall saves us about nine minutes of case time for every patient. And this adds up so this allows us to do more cases in one day. And the patients just love it because they don't have to have the hassle of transferring from one place to the other there.

They are already nervous after the laser. And they get more nervous when they're transferred to another room. So our patients are very happy. And right now we've done about 70 eyes with wonderful results. So I encourage you all to get this into your operating theatres. You'll be able to get good outcomes in much shorter time. Thank you.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.